Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan
CONCLUSION: Our data indicate that if aggressive lymphoid neoplasms develop during the course of treatment in patients with MPNs, it is acceptable to prioritize chemotherapy for lymphoma.PMID:38626148 | DOI:10.1080/16078454.2024.2340149
Source: Hematology - Category: Hematology Authors: Yoko Edahiro Tomonori Ochiai Yoshinori Hashimoto Michiko Ichii Takeshi Okatani Hiromi Omura Kei Nakajima Makoto Sasaki Jun Ando Tomoiku Takaku Michiaki Koike Koh Izumiyama Junji Hiraga Tomofumi Yano Kensuke Usuki Eiichi Ohtsuka Kenji Yokoyama Tatsuo Oyake Source Type: research
More News: Cancer & Oncology | Chemotherapy | Chronic Leukemia | Chronic Lymphocytic Leukemia | Hematology | Japan Health | Leukemia | Lymphoma | Myeloma | Myeloproliferative Disorders | Study